Wellgistics Health (NASDAQ:WGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Wellgistics Health (NASDAQ:WGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Datavault AI Licenses Patents Covering Digital Ledger-Enabled Smart Contracts for Commercial Prescription Drug Distribution Industry to Wellgistics Health [Yahoo! Finance]
Wellgistics Health (NASDAQ:WGRX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Wellgistics Health GAAP EPS of -$0.46, revenue of $3.01M [Seeking Alpha]